Vanuatu

Reimbursed Care Access

Vanuatu regulates controlled substances under its Dangerous Drugs Act (Cap. 12) and enforces strict criminal penalties for unauthorised possession, importation, sale or supply; classical psychedelics (psilocybin, MDMA, DMT, mescaline, 5‑MeO‑DMT, 2C‑series, ibogaine, ayahuasca) have no authorised medical use outside approved research. Ketamine is available and used medically (primarily as an anaesthetic/analgesic) in health facilities in line with international essential‑medicine guidance, but there is no public programme reimbursing psychedelic‑assisted therapies and no publicly documented regulatory approval or reimbursement pathway for esketamine or psychedelic medicines in Vanuatu. [https://extranet.who.int/mindbank/item/1526|WHO MiNDbank — Dangerous Drugs Act (Vanuatu)] [https://vanuatucustoms.gov.vu/customs/services/prohibitions-restrictions.html|Vanuatu Customs — Prohibitions & Restrictions] [https://www.who.int/publications/i/item/WHO-MVP-EMP-EML-2021.02|WHO Model List of Essential Medicines (ketamine listed)]